Benitec Biopharma Ownership | Who Owns Benitec Biopharma?

Benitec Biopharma Ownership Summary

Benitec Biopharma is owned by 58.77% institutional investors, 3.12% insiders, and 38.11% retail investors. Suvretta capital management is the largest institutional shareholder, holding 25.59% of BNTC shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 5.70% of its assets in Benitec Biopharma shares.

BNTC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Benitec Biopharma	58.77%	3.12%	38.11%
Sector	Healthcare Stocks	487.91%	11.08%	-398.99%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Suvretta capital management	9.88M	25.59%	$115.56M
Adage capital partners gp	1.97M	5.11%	$23.08M
Nantahala capital management	838.10K	2.17%	$9.81M
Blackrock funding, inc. /de	718.69K	1.86%	$8.41M
Silverarc capital management	253.23K	0.66%	$2.96M
Awm investment company	137.98K	0.36%	$1.61M
Simplify asset management	78.72K	0.22%	$1.10M
Exoduspoint capital management, lp	76.38K	0.20%	$894.00K
Myda advisors	62.12K	0.16%	$726.76K
Marshall wace, llp	43.00K	0.11%	$503.13K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Suvretta capital management	9.88M	3.48%	$115.56M
Silverarc capital management	253.23K	0.55%	$2.96M
Nantahala capital management	838.10K	0.38%	$9.81M
Awm investment company	137.98K	0.18%	$1.61M
Myda advisors	62.12K	0.13%	$726.76K
Adage capital partners gp	1.97M	0.04%	$23.08M
Simplify asset management	78.72K	0.02%	$1.10M
Anson funds management lp	11.71K	0.02%	$137.01K
Exoduspoint capital management, lp	76.38K	0.01%	$894.00K
Xtx topco	10.85K	0.01%	$126.89K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	718.69K	0.00%	534.26K
Marshall wace, llp	43.00K	0.00%	43.00K
Anson funds management lp	11.71K	0.02%	11.71K
Xtx topco	10.85K	0.01%	10.85K
Myda advisors	62.12K	0.13%	10.12K

Top Sellers

Holder	Shares	% Assets	Change
Hrt financial lp	-	-	-25.93K
Qube research	-	-	-19.00K
Sg americas securities	-	-	-8.46K
Exoduspoint capital management, lp	76.38K	0.01%	-6.82K
Balyasny asset management	-	-	-2.82K

New Positions

Holder	Shares	% Assets	Change	Value
Marshall wace, llp	43.00K	0.00%	43.00K	$503.13K
Anson funds management lp	11.71K	0.02%	11.71K	$137.01K
Xtx topco	10.85K	0.01%	10.85K	$126.89K
Truvestments capital	1.17K	0.00%	1.17K	$13.74K
Eversource wealth advisors	148.00	0.00%	148.00	$1.73K

Sold Out

Holder	Change
Balyasny asset management	-2.82K
Sg americas securities	-8.46K
Qube research	-19.00K
Hrt financial lp	-25.93K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	56	51.35%	22,685,531	3.62%	58	1.83%	37	42.31%	12	100.00%
Mar 31, 2025	36	20.00%	21,891,366	15.23%	56	0.77%	25	8.70%	6	50.00%
Dec 31, 2024	30	20.00%	18,997,897	38.52%	86	0.52%	23	91.67%	4	-50.00%
Sep 30, 2024	25	31.58%	13,715,023	115.83%	128	3.36%	12	-20.00%	8	300.00%
Jun 30, 2024	1	-	625,000	-	23	-	1	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Franklin Biotechnology Discv A(acc)USD	1.50M	5.70%	-
HBM Healthcare Investments AG Ord	1.19M	4.54%	-
Franklin Biotechnology Discovery A	1.15M	4.38%	-55.29K
Vanguard Total Stock Mkt Idx Inv	495.12K	1.89%	-10.91K
Janus Henderson Hrzn Biotec E2 USD	424.25K	1.62%	-16.16K
iShares Russell 2000 ETF	324.08K	1.23%	-
Vanguard Institutional Extnd Mkt Idx Tr	233.91K	0.89%	-98.52K
Fidelity Small Cap Index	145.41K	0.55%	145.41K
iShares Russell 2000 Growth ETF	123.00K	0.47%	-
Fidelity Extended Market Index	115.50K	0.44%	-950.00

Recent Insider Transactions

Date	Name	Activity	Value
Mar 31, 2025	SUVRETTA CAPITAL MANAGEMENT, LLC	Buy	$16.00K
Mar 31, 2025	SUVRETTA CAPITAL MANAGEMENT, LLC	Buy	$120.02K
Mar 31, 2025	SUVRETTA CAPITAL MANAGEMENT, LLC	Buy	$66.85K
Mar 31, 2025	SUVRETTA CAPITAL MANAGEMENT, LLC	Buy	$8.86K
Mar 26, 2025	SUVRETTA CAPITAL MANAGEMENT, LLC	Buy	$1.38M

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	6	-
2024 Q4	10	-
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-

BNTC Ownership FAQ

Who Owns Benitec Biopharma?

Benitec Biopharma shareholders are primarily institutional investors at 58.77%, followed by 3.12% insiders and 38.11% retail investors. The average institutional ownership in Benitec Biopharma's industry, Biotech Stocks , is 307.10%, which Benitec Biopharma falls below.

Who owns the most shares of Benitec Biopharma?

Benitec Biopharma’s largest shareholders are Suvretta capital management (9.88M shares, 25.59%), Adage capital partners gp (1.97M shares, 5.11%), and Nantahala capital management (838.1K shares, 2.17%). Together, they hold 32.87% of Benitec Biopharma’s total shares outstanding.

Does Blackrock own Benitec Biopharma?

BlackRock is not among the top 10 institutional shareholders of Benitec Biopharma.

Who is Benitec Biopharma’s biggest shareholder by percentage of total assets invested?

Suvretta capital management is Benitec Biopharma’s biggest shareholder by percentage of total assets invested, with 3.48% of its assets in 9.88M Benitec Biopharma shares, valued at 115.56M$.

Who is the top mutual fund holder of Benitec Biopharma shares?

Franklin Biotechnology Discv A(acc)USD is the top mutual fund holder of Benitec Biopharma shares, with 5.70% of its total shares outstanding invested in 1.5M Benitec Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools